INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
ANBESOL*

SCHEDULING STATUS:
S1

PROPRIETARY NAME
(and dosage form):

ANBESOL*

COMPOSITION:
Each 100 mg contains:

	Lignocaine Hydrochloride	0,90 mg
	Chlorocresol	0,10 mg
	Cetylpyridinium Chloride	0,02 mg
	Alcohol 95%	68,24% m/m

PHARMACOLOGICAL CLASSIFICATION:
A 13.4.2 Dermatological Preparations (Other)

PHARMACOLOGICAL ACTION:
Lignocaine Hydrochloride has a local anaesthetic action when applied to skin or the mucous membrane. ANBESOL* has local anaesthetic and antiseptic properties.

INDICATIONS:
ANBESOL* is useful as a local anaesthetic and antiseptic. ANBESOL* may be used to help alleviate pain and discomfort caused by minor irritations from cold sores, fever blisters, denture irritation/sore gums.

CONTRA-INDICATIONS:
Hypersensitivity. Not for prolonged use. If pain, redness, rash, irritation or swelling persists, or if infection occurs, discontinue use and consult a doctor or dentist.

DOSAGE AND DIRECTIONS FOR USE
Apply ANBESOL* undiluted to the affected area with finger-tip or a swab of cotton wool. ANBESOL* may be applied every 30 minutes, but should not be used for longer than two consecutive days.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
A transient, stinging sensation on application. Local usage is more likely to cause allergic reactions. Do not exceed the recommended dose. Patients with liver disease should only apply ANBESOL* at hourly intervals.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Antihistaminics, corticosteroids or adrenalin may be used for the treatment of:
hypersensitivity allergic reactions;
respiratory failure and convulsions.
Treatment of overdosage is symptomatic.

IDENTIFICATION:
ANBESOL* is a clear, colourless liquid with a fresh antiseptic odour.

PRESENTATION:
15 mL amber glass bottle.

STORAGE INSTRUCTIONS:
Store in a cool (under 25 °C) dark place.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
J/13.4.2/344

NAME AND BUSINESS ADDRESS OF APPLICANT:
S.A.D SELF MEDICATION [PTY] LIMITED
[Co. Reg. No. 92/04769/07]
Robbie de Lange Road, Wilsonia, EAST LONDON 5201

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
30 MAY 1983

*REGISTERED TRADEMARK
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998